ArticleJournal of pharmaceutical health care and sciences2024

Safety of talimogene laherparepvec: a real-world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS).

Yifan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.